Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 651-662

  Crawley, Allison C ^a   Niedzielski, Krystyna H ^a   Isaac, Elizabeth L ^a   Davey, Richard C A ^a   Byers, Sharon ^a   Hopwood, John J ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

disease models, animal; dysostoses; genetics, medical; lysosomal storage diseases; mucopolysaccharidosis VI

Indexed keywords

DERMATAN SULFATE; N ACETYLGALACTOSAMINE 4 SULFATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BONE DENSITY; BONE MARROW TRANSPLANTATION; CAT; CELL VACUOLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME REPLACEMENT; MORQUIO SYNDROME; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 0031029536     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119208     Document Type: Article

References (41)

1. Neufeld, E.F., and J. Muenzer. 1995. The mucopolysaccharidoses. In The Metabolic and Molecular Basis of Inherited Disease. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 2465-2494.
2. Jezyk, P.F., M.E. Haskins, D.F. Patterson, W.J. Mellman, and M. Greenstein. 1977. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science (Wash. DC). 198:834-836.
3. Haskins, M.E., G.D. Aguirre, P.F. Jezyk, and D.F. Patterson. 1980. The pathology of the feline model of mucopolysaccharidosis VI. Am. J. Pathol. 101: 657-674.
4. Yoshida, M., H. Ikadai, A. Maekawa, M. Takahashi, and S. Nagase. 1993. Pathological characteristics of mucopolysaccharidosis VI in the rat. J. Comp. Pathol. 109:141-153.
5. Yoshida, M., J. Noguchi, H. Ikadai, M. Takahashi, and S. Nagase. 1993. Arylsulfatase B deficient mucopolysaccharidosis in rats. J. Clin. Invest. 91:1099-1104.
6. Evers, M., P. Saftig, P. Schmidt, A. Hafner, D.B. McLoghlin, W. Schmahl, B. Hess, K. von Figura, and C. Peters. 1996. Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc. Natl. Acad. Sci. USA. 93:8214-8219.
7. Hopwood, J.J., A. Vellodi, H.S. Scott, C.P. Morris, T. Litjens, P.R. Clements, D.A. Brooks, A. Cooper, and J.E. Wraith. 1993. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J. Inherited Metab. Dis. 16:1024-1033.
8. Hoogerbrugge, P.M., O.F. Brouwer, P. Bordigoni, O. Ringden, P. Kapaun, J.J. Ortega, A. O'Meara, G. Cornu, G. Souillet, D. Frappaz, et al. 1995. Allogeneic bone marrow transplantation for lysosomal storage diseases. Lancet (N. Am. Ed.). 345:1398-1402.
9. Krivit, W., M.E. Pierpont, K. Ayaz, M. Tsai, N.K. Ramsay, J.H. Kersey, S. Weisdorf, R. Sibley, D. Snover, M.M. McGovern, et al. 1984. Bone marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N. Engl. J. Med. 311:1606-1611.
10. McGovern, M.M., M.D. Ludman, M.P. Short, L. Steinfeld, M. Kattan, E.L. Raab, W. Krivit, and R.J. Desnick. 1986. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT. In Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases. W. Krivit and N. Paul, editors. Birth Defects Orig. Artic. Ser. 22:41-53.
11. Krivit, W. 1992. Maroteaux-Lamy syndrome type VI treatment by allogeneic bone marrow transplantation in six patients and potential for autotransplantation genetic therapy. Int. Pediatr. 7:47.
12. Krivit, W., J.H. Sung, L.A. Lockman, and E.G. Shapiro. 1995. Bone marrow transplantation for treatment of lysosomal and peroxisomal storage diseases: focus on CNS reconstitution. In Principles of Clinical Immunology. Vol. 2. R.R. Rich, T.A. Fleisher, B.O. Schwartz, W.T. Shearer, and W. Strober, editors. Mosby, St. Louis, MO. 1859-1860.
13. Barton, N.W., F.S. Furbish, G.J. Murray, M. Garfield, and R.O. Brady. 1990. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. USA. 87:1913-1916.
14. Barton, N.W., R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, S.C. Hill, H.J. Mankin, G.J. Murray, R.I. Parker, C.E. Argoff, et al. 1991. Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 324:1464-1470.
15. Hollak, C.E., J.M. Aerts, R. Goudsmit, S.S. Phoa, M. Ek, S. van Weely, A.E. von dem Borne, and M.H. van Oers. 1995. Individualised low-dose aglucerase therapy for type 1 Gaucher's disease. Lancet (N. Am. Ed.). 345:1474-1478.
16. Vogler, C., M. Sands, A. Higgins, B. Levy, J. Grubb, E.H. Birkenmeier, and W.S. Sly. 1993. Enzyme replacement with recombinant β-glucuronidase in the newborn mucopolysaccharidosis type VII Mouse. Pediatr. Res. 34:837-840.
17. Sands, M.S., C. Vogler, J.W. Kyle, J.H. Grubb, B. Levy, N. Galvin, W.S. Sly, and E.H. Birkenmeier. 1994. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest. 93:2324-2331.
18. Shull, R.M., E.D. Kakkis, M.F. McEntee, S.A. Kania, A.J. Jonas, and E.F. Neufeld. 1994. Enzyme replacement in a canine model of Hurler syndrome. Proc. Natl. Acad. Sci. USA. 91:12937-12941.
19. Crawley, A.C., D.A. Brooks, V.J. Muller, B.A. Petersen, E.L. Isaac, J. Bielicki, B.M. King, C.D. Boulter, A.J. Moore, N.L. Fazzalari, D.S. Anson, S. Byers, and J.J. Hopwood. 1996. Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome. J. Clin. Invest. 97:1864-1873.
20. Vogler, C., M.S. Sands, B. Levy, N. Galvin, E.H. Birkenmeier, and W.S. Sly. 1996. Enzyme replacement with recombinant β-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Pediatr. Res. 39: 1050-1054.
21. Haskins, M.E., P.F. Jezyk, and D.F. Patterson. 1979. Mucopolysaccharide storage disease in three families of cats with arylsulfatase B deficiency: leukocyte studies and carrier identification. Pediatr. Res. 13:1203-1210.
22. Gold, E. 1979. A simple spectrophotometric method for estimating glycosaminoglycan concentrations. Anal. Biochem. 99:183-188.
23. Yogalingam, G., T. Litjens, J. Bielicki, A.C. Crawley, V. Muller, D.S. Anson, and J.J. Hopwood. 1996. Feline mucopolysaccharidosis type VI: characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease. J. Biol. Chem. 271:27259-27265.
24. Konde, L.J., M.A. Thrall, P. Gasper, S.M. Dial, K. McBiles, S. Colgan, and M. Haskins. 1987. Radiographically visualized skeletal changes associated with mucopolysaccharidosis VI in cats. Vet. Radiol. 28:223-228.
25. Blumenkrantz, N., and G. Asboe-Hansen. 1973. New method for quantitative determination of uronic acids. Anal. Biochem. 54:484-489.
26. Hopwood, J.J., and J.R. Harrison. 1982. High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. Anal. Biochem. 119:120-127.
27. Berman, E. 1986. Fetal and neonatal growth and development. In Current Therapy in Theriogenology. D.A. Morrow, editor. W.B. Saunders Co., Philadelphia. 801-804.
28. Wenger, D.A., P.W. Gasper, M.A. Thrall, S.M. Dial, R.A. LeCouteur, and E.A. Hoover. 1986. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. In Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases. W. Krivit and N. Paul, editors. Birth Defects Orig. Artic. Ser. 22:177-186.
29. Haskins, M., H.J. Baker, E. Birkenmeier, P.M. Hoogerbrugge, B.J. Poorthuis, T. Sakiyama, R.M. Shull, R.M. Taylor, M.A. Thrall, and S.U. Walkley. 1991. Transplantation in animal model systems. In Treatment of Genetic Diseases. R.J. Desnick, editor. Churchill Livingstone, New York. 183-201.
30. Norrdin, R.W., K.S. Moffat, M.A. Thrall, and P.W. Gasper. 1993. Characterization of osteopenia in feline mucopolysaccharidosis VI and evaluation of bone marrow transplantation therapy. Bone (NY). 14:361-367.
31. Turner, A.S., R.W. Norrdin, S. Gaarde, H.E. Connally, and M.A. Thrall. 1995. Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy x-ray absorptiometry. Calcif. Tissue Int. 57:191-195.
32. Aguirre, G., I. Raber, M. Yanoff, and M. Haskins. 1992. Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage. Invest. Ophthalmol. Vis. Sci 33:2702-2713.
33. Birkenmeier, E.H., J.E. Barker, C.A. Vogler, J.W. Kyle, W.S. Sly, B. Gwynn, B. Levy, and C. Pegors. 1991. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood. 78:3081-3092.
34. Breider, M.A., R.M. Shull, and G. Constantopoulos. 1989. Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. Am. J. Pathol. 134:677-692.
35. Richards, S.M., T.A. Olson, and J.M. McPherson. 1993. Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase. Blood. 82:1402-1409.
36. Menon, K.P., P.T. Tieu, and E.F. Neufeld. 1992. Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I. Genomics. 14:763-768.
37. Shull, R.M., X. Lu, M.F. McEntee, R.M. Bright, K.A. Pepper, and D.B. Kohn. 1996. Myoblast gene therapy in canine mucopolysaccharidosis I: abrogation by an immune response to α-L-iduronidase. Hum. Gene Ther. 7:1595-1603.
38. Di Ferrante, N. 1967. The measurement of urinary mucopolysaccharides. Anal. Biochem. 21:98-106.
39. Varadi, D.P., J.A. Cifonelli, and A. Dorfman. 1967. The acid mucopolysaccharides in normal urine. Biochim. Biophys. Acta. 141:103-117.
40. Alroy, J., G.O. Freden, V. Goyal, S.S. Raghavan, and K.L. Schunk. 1989. Morphology of leukocytes from cats affected with α-mannosidosis and mucopolysaccharidosis VI (MPS VI). Vet. Pathol. 26:294-302.
41. Haskins, M.E., S.A. Bingel, J.W. Northington, C.D. Newton, R.D. Sande, P.F. Jezyk, and D.F. Patterson. 1983. Spinal cord compression and hindlimb paresis in cats with mucopolysaccharidosis VI. J. Am. Vet. Med. Assoc. 182:983-985.